Introduction: Drug discovery approach are usually performed using affinity or potency parameters. Copeland et al. (Nat. Rev. Drug Discov. 2006, 9:730-739) proposed that the time that a ligand spends in its binding site (residence time, 1/koff) could have a major influence on its clinical efficacy. There is an interest in searching for new Na+/K+-ATPase (NKA, EC 3.6.3.9) modulators targeting clinical conditions such as cancer (Slingerland et al., New Drugs 2013, 31:1087–1094). We performed a Structure-Kinetic Relationship to study the influence of kinetics of NKA inhibition.
Methods: 17 CS natural and synthesized (Wang et al., ACS Med. Chem. Lett. 2011, 2:264-269) was tested to inhibit the K+-dependent?phosphatase activity performed at different temperature and ionic condition. The association rate (kon) and dissociation rate (koff) constants were obtained by globally fitting the inhibition vs. time of each compound using the following equation: y?=?Imax ([I]/([I]+Ki))1?e(?1(kon[I]+koff)t).
Results: Changing conditions (from ATPase to p-NPPase activity) resulted in an increase of Ki of the cardenolides due to a reduction of kon, in contrast to the Ki of the structurally related bufadienolide. When evaluating the kinetics of 17 natural and semi-synthetic CTS, we observed that both kon and koff correlated with Ki (Spearman test), showing that 4 CTS has the same potence but different kinetics. A rhamnose in C3 of the steroidal nucleus enhanced the inhibitory potency by a reduction of koff rather than an increase of kon. Rising the temperature did not alter the koff of a glycosylated CS, generating a ?H‡ (koff) of -10.4 ± 4.3 kJ/mol, suggesting a complex dissociation mechanism.
Conclusion: Based on a simple and inexpensive methodology, we determined the values of kon, koff, and Ki of the CTS and provided original kinetics and thermodynamics differences between CTS that could help the design of new compounds.
Dear Colleagues and Friends,
We are thrilled to extend a warm welcome to the 8th Annual Meeting of the Cardiotonic Steroids and Na Pump, in collaboration with the Brazilian Society of Pharmacology and Experimental Therapeutic Society (SBFTE) and the Brazilian Society for Biochemistry and Molecular Biology (SBBq). The event is scheduled to take place at the Federal University of São João del Rei (UFSJ) from August 20th to 23rd, 2024.
The Na pump meeting stands as one of Brazil's most enduring scientific gatherings. Over the past decade, it has been hosted by various Brazilian institutions, serving as a pivotal platform for scientific discussions that contribute significantly to the advancement of fundamental knowledge in Na, K-ATPase biochemistry, molecular biology, and related fields. Additionally, it serves as a forum for dialogues on scientific education and training, generating consensus that can influence public policies for the betterment of society.
For this year's meeting, the organizing committee has curated an engaging interdisciplinary program, featuring lectures by esteemed foreign scientists. These sessions will delve into the latest advancements and current challenges across a broad spectrum of research topics in Biochemistry and the Molecular Na pump signaling cascade.
We eagerly anticipate your participation in this exciting scientific event and hope to see you soon in Minas Gerais!
Best regards,
Scientific Committee
Comissão Organizadora
Dr Leandro Augusto Barbosa
Dr Vanessa Faria Cortes
Sílvia Ramos Silva
Marina Vieira
Anna Karolina de Oliveira Alfenas Gadelha - Mídias Sociais e Papelaria
Jessica Alves Faria - Coffee Break e Gráfica
Lucas Antônio Lisboa Ribeiro - Apresentação/Cerimonial
Poliana Amorim Santos - Abertura/ Encerramento/ parte recreativa
?Ana Gabriela Finamore dos Santo-Midias Sociais e Suporte Técnico.
Thiago Malverde de Oliveira - Divulgação (SJDR) e suporte
Maurício Gustavo Oliveira - Credenciamento
Ítalo Leonardo Diogo - Contato com a pós-graduação e Controle de Frequência
Julia Lopes Granato - Midias sociais e controle de frequência
Comissão Científica
Dr. Gustavo Blanco – Kansas University Medical Center, USA
Dr. John Hamlyn – University of Maryland, USA
Dr. Rúben Gerardo Contreras Patiño – CINVESTAV, Mexico
Dra. Vanessa Faria Cortes - Federal University of São João del-Rei, Brazil
Dr Carlos Frederico Leite Fontes - Federal University of Rio de Janeiro, Brazil
Dr Cristoforo Scavone - University of Sao Paulo
a